| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Selective RAF inhibitor impairs ERK1/2 phosphorylation and growth in mutant NRAS, vemurafenib-resistant melanoma cells. | Pigment Cell Melanoma Res | 2013 | 1.13 |
| 2 | Intestinal GUCY2C prevents TGF-β secretion coordinating desmoplasia and hyperproliferation in colorectal cancer. | Cancer Res | 2013 | 0.86 |
| 3 | New advances in models and strategies for developing anti-obesity drugs. | Expert Opin Drug Discov | 2013 | 0.79 |